Editorial draft — not for publication yet. Carisoprodol content needs clinical and legal review before publication. This is general information, not a legal decision about a product or action.
Quick answer
Carisoprodol was used as a centrally acting muscle relaxant for short-term treatment of painful musculoskeletal conditions associated with muscle spasm. It was intended as an adjunct to rest, physical measures and other care, rather than as a treatment for every cause of back or muscle pain.
Historical use in painful muscle spasm
That description is historical. Carisoprodol is not licensed for routine UK use. A former indication, a product leaflet from another country or a brand name such as Carisoma does not amount to a current UK recommendation.
Why its use was discontinued in the UK
The European review concluded that the benefits no longer outweighed the risks. The MHRA described risks including abuse, addiction, intoxication and psychomotor impairment, and noted safer alternatives for acute musculoskeletal conditions. The UK marketing authorisations were withdrawn; the ACMD later confirmed that the medicine is unlicensed in the UK.
Current UK drug-harm evidence also raises concern about dependence and overdose, especially when it is taken with opioids or benzodiazepines. This safety profile is one reason not to infer that an overseas treatment plan can simply be continued without review in the UK.
What to discuss for muscle spasm now
Muscle spasm is a symptom, not a diagnosis. A clinician may need to assess the cause, how the pain began, whether there was an injury, other symptoms and your health history before discussing care. Do not use carisoprodol bought online or an old supply as a substitute for that assessment.
For low back pain, NICE recommends tailored information and support for self-management, including advice to continue normal activities where possible. NHS guidance on sprains and strains describes self-care and when to seek further assessment. The right approach depends on the cause and red flags.
Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.
Frequently asked questions
Was carisoprodol used for back pain?
It was historically used short term for painful musculoskeletal conditions with muscle spasm. It is not licensed for routine UK use now.
Why was carisoprodol withdrawn?
A European review concluded that risks outweighed benefits, with concerns including abuse, addiction, intoxication and impaired psychomotor performance.
What should I do for muscle spasm instead?
Ask a GP, pharmacist or NHS musculoskeletal service to assess the cause and discuss suitable care. The right option depends on the symptoms and your health.
Sources and further reading
This page is based on the UK sources below. Legal status can change; check the latest legislation and its commencement date before relying on it.
- GOV.UK / ACMD: ACMD review: use, harms and UK status of carisoprodol
- MHRA / GOV.UK: Carisoprodol and meprobamate: risks outweigh benefits
- NICE: Low back pain and sciatica in over 16s (NG59)
- NHS: Sprains and strains
Editorial status: Editorial draft — clinical and legal review required before publication. Sources checked on 2 October 2026.
Related information
Read the Carisoprodol overview or continue to another topic: